Association between low-level environmental arsenic exposure and qt interval duration in a general population study

American Journal of Epidemiology

Volumn 170, Issue 6, 2009, Pages 739-746

  Mordukhovich, Irina ^a   Wright, Robert O ^b,c   Amarasiriwardena, Chitra ^c   Baja, Emmanuel ^b   Baccarelli, Andrea ^b,d   Suh, Helen ^b   Sparrow, David ^e   Vokonas, Pantel ^e   Schwartz, Joel ^b,c  

^a IL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF MILAN   (Italy)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidants; Arrhythmias, cardiac; Arsenic; Calcium channel blockers; Cardiovascular diseases; Environmental health; Long QT syndrome

Indexed keywords

ANTIOXIDANT; ARSENIC; ASCORBIC ACID; CALCIUM CHANNEL BLOCKING AGENT; CAROTENE; RETINOL;

ANTIOXIDANT; ARSENIC; CARDIOVASCULAR DISEASE; CONCENTRATION (COMPOSITION); DISEASE TREATMENT; ENVIRONMENTAL RISK; HEALTH RISK; POLLUTION EXPOSURE; REGRESSION ANALYSIS;

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG USE; ENVIRONMENTAL EXPOSURE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAIL; OXIDATIVE STRESS; QT INTERVAL; QT PROLONGATION; TOE;

ADULT; AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; ARSENIC; ARSENICALS; CALCIUM CHANNEL BLOCKERS; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DEATH, SUDDEN, CARDIAC; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL EXPOSURE; HUMANS; LONG QT SYNDROME; MALE; MIDDLE AGED; NAILS; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK FACTORS; UNITED STATES;

BOSTON; MASSACHUSETTS; NORTH AMERICA; UNITED STATES;

EID: 69949112778     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwp191     Document Type: Article

References (36)

1. Scott JL, Walls RM. QT interval prolongation. J Emerg Med. 1985;3(3):221-225.
2. Straus SM, Kors JA, De Bruin ML, et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol. 2006;47(2):362-367.
3. Ficker E, Kuryshev YA, Dennis AT, et al. Mechanisms of arsenic-induced prolongation of cardiac repolarization. Mol Pharmacol. 2004;66(1):33-44. (Pubitemid 38822085)
4. Sun HL, Chu WF, Dong DL, et al. Choline-modulated arsenic trioxide-induced prolongation of cardiac repolarization in guinea pig. Basic Clin Pharmacol Toxicol. 2006;98(4):381-388.
5. Hall JC, Harruff R. Fatal cardiac arrhythmia in a patient with interstitial myocarditis related to chronic arsenic poisoning. South Med J. 1989;82(12):1557-1560. (Pubitemid 20015913)
6. Little RE, Kay GN, Cavender JB, et al. Torsade de pointes and T-U wave alternans associated with arsenic poisoning. Pacing Clin Electrophysiol. 1990; 13(2): 164-170.
7. Chiang CE, Luk HN, Wang TM, et al. Prolongation of cardiac repolarization by arsenic trioxide. Blood. 2002; 100(6):2249-2252.
8. Westervelt P, Brown RA, Adkins DR, et al. Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide. Blood. 2001 ;98(2):266-271.
9. Barbey JT, Pezzullo JC, Soignet SL. Effect of arsenic trioxide on QT interval in patients with advanced malignancies. J Clin Oncol. 2003;21(19):3609-3615. (Pubitemid 46594053)
10. Ohnishi K, Yoshida H, Shigeno K, et al. Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia. Ann Intern Med. 2000;133(11):881-885.
11. Mumford JL, Wu K, Xia Y, et al. Chronic arsenic exposure and cardiac repolarization abnormalities with QT interval prolongation in a population-based study. Environ Health Perspect. 2007;115(5):690-694. (Pubitemid 46785037)
12. Yildiz A, Karaca M, Biceroglu S, et al. Effect of chronic arsenic exposure from drinking waters on the QT interval and transmural dispersion of repolarization. J Int Med Res. 2008; 36(3):471-478. (Pubitemid 351833596)
13. Ahmad SA, Khatun F, Sayed MH, et al. Electrocardiographic abnormalities among arsenic-exposed persons through groundwater in Bangladesh. J Health Popul Nutr. 2006;24(2): 221-227. (Pubitemid 46151827)
14. Yamazaki K, Terada H, Satoh H, et al. Arrhythmogenic effects of arsenic trioxide in patients with acute promyelocytic leukemia and an electrophysiological study in isolated guinea pig papillary muscles. Circ J. 2006;70(11):1407-1414. (Pubitemid 44672895)
15. Flora SJ, Bhadauria S, Kannan GM, et al. Arsenic induced oxidative stress and the role of antioxidant supplementation during chelation: a review. J Environ Biol. 2007;28(2 suppl): 333-347. (Pubitemid 46683614)
16. Bell B, Rose CL, Damon A. The Normative Aging Study: an interdisciplinary and longitudinal study of health and aging. Aging Hum Dev. 1972;3:5-17.
17. Roberts WL, Moulton L, Law TC, et al. Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem. 2001;47:418-425. (Pubitemid 32222454)
18. Leon L, Chu D, Stasiw R. New, More Specific Methods for the SMA 12/60 Multichannel Biochemical Analyzer: Advances in Automated Analysis. Tarrytown, NY: Mediad; 1977.
19. Bell B, Rose CL, Damon A. The Veterans Administration longitudinal study of health aging. Gerontologist. 1966;6(4): 179-184.
20. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985;122(1):51-65. (Pubitemid 15010435)
21. Park SK, O'Neill MS, Vokonas PS, et al. Effects of air pollution on heart rate variability: the VA Normative Aging Study. Environ Health Perspect. 2005; 113(3):304-309. (Pubitemid 40450662)
22. Pope CA III, Eatough DJ, Gold DR, et al. Acute exposure to environmental tobacco smoke and heart rate variability. Environ Health Perspect. 2001 ;109(7):711-716. (Pubitemid 32791306)
23. Bednar MM, Harrigan EP, Anziano RJ, et al. The QT interval. Prog Cardiovasc Dis. 2001;43(5 suppl.1):1-45.
24. Hekkala AM, Väänänen H, Swan H, et al. Reproducibility of computerized measurements of QT interval from multiple leads at rest and during exercise. Ann Noninvasive Electrocardiol. 2006;11(4):318-326. (Pubitemid 44564297)
25. Slotnick MJ, Nriagu JO. Validity of human nails as a biomarker of arsenic and selenium exposure: a review. Environ Res. 2006;102(1):125-139.
26. Agency for Toxic Substances and Disease Registry. Toxicological Profile for Arsenic. Atlanta, GA: US Department of Health and Human Services; 2007.
27. Karagas MR, Tosteson TD, Blum J, et al. Measurement of low levels of arsenic exposure: a comparison of water and toenail concentrations. Am J Epidemiol. 2000;152(1):84-90. (Pubitemid 30637401)
28. Slotnick MJ, Meliker JR, AvRuskin GA, et al. Toenails as a biomarker of inorganic arsenic intake from drinking water and foods. J Toxicol Environ Health A. 2007;70(2): 148-158. (Pubitemid 46269421)
29. Benbrahim-Tallaa L, Waalkes MP. Inorganic arsenic and human prostate cancer. Environ Health Perspect. 2008; 116(2): 158-164. (Pubitemid 351356720)
30. Zhao XY, Li GY, Liu Y, et al. Resveratrol protects against arsenic trioxide-induced cardiotoxicity in vitro and in vivo. Br J Pharmacol. 2008;154(1): 105-113. (Pubitemid 351620407)
31. Willcox BJ, Curb JD, Rodriguez BL. Antioxidants in cardiovascular health and disease: key lessons from epidemiologic studies. Am J Cardiol. 2008;101(10A):75D-86D.
32. Palace VP, Khaper N, Qin Q, et al. Antioxidant potentials of vitamin A and carotenoids and their relevance to heart disease. Free Radie Biol Med. 1999;26(5-6):746-761. (Pubitemid 29146279)
33. Gey KF. Prospects for the prevention of free radical disease, regarding cancer and cardiovascular disease. Br Med Bull. 1993;49(3):679-699.
34. Newton-Cheh C, Shah R. Genetic determinants of QT interval variation and sudden cardiac death. Curr Opin Genet Dev. 2007;17(3):213-221. (Pubitemid 46850800)
35. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349): 1903-1913. (Pubitemid 35472129)
36. Huxley R, Lewington S, Clarke R. Cholesterol, coronary heart disease and stroke: a review of published evidence from observational studies and randomized controlled trials. Semin Vase Med. 2002;2(3):315-323.